サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血流測定装置の世界市場-2023年～2030年
市場調査レポート
商品コード
1373368

血流測定装置の世界市場-2023年～2030年

Global Blood Flow Measurement Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血流測定装置の世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

血流測定装置は、人体内の血流にアクセスして定量化するために設計されています。これらの機器は、心臓病学、血管外科、神経学など様々な医療専門分野で重要な役割を果たしています。

血流計は様々な血管内の血流をモニターし、心拍出量を測定するために使用されます。超音波ドップラー、トランジットタイム流量計、電磁式血流計、プレチスモグラフィーチャンバー流量計などが一般的に使用される血流測定装置です。

市場力学

製品発売の増加

足部血流測定装置の製品発売が増加していることは、市場成長の重要な促進要因となっています。また、多くの重要な企業が新しい血流測定装置を発売することで、市場の進歩に大きな役割を果たしています。

例えば、2023年6月、Stat Health社は血流を測定する耳かけ型ウェアラブルを発売しました。これは、めまい、脳霧、頭痛、失神、疲労などの症状を理解するのに役立つように設計されたウェアラブルです。

さらに、2021年4月、NovaSignal Corp.は、自律的に血流を測定して脳の病気や疾患を特定するNovaGuide 2 Intelligent Ultrasoundを発売しました。

さらに、世界の血流測定市場は、心血管疾患の有病率の上昇、技術の進歩、血流測定装置に対する需要の増加など、さまざまな要因によって牽引されており、予測期間における市場の牽引役となることが期待されています。

厳しい規制当局の承認

血流測定装置に対する規制当局の厳しい承認は、精度、信頼性、安全性に関する特定の基準を確保するために、装置の厳格な試験と評価を伴うため、市場の成長を妨げる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 製品上市の増加
      • YY社
    • 抑制要因
      • 厳しい規制当局の承認
      • YY社
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMI意見

第6章 COVID-19分析

第7章 機器タイプ別

  • 超音波デバイス
    • 超音波ドップラー
    • トランジットタイムフローメーター
  • レーザードップラー
  • 電磁式血流計
  • プレチスモグラフィチャンバー流量計

第8章 アプリケーション別

  • 侵襲的
    • CABG
    • 微小血管手術
  • 非侵襲的
    • 糖尿病
    • 心血管疾患
    • 腫瘍モニタリング
    • 消化器病学
    • その他

第9章 エンドユーザー別

  • 病院
  • クリニック
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Cook Medical Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Medistim ASA
  • Transonic Systems, Inc.
  • Deltex Medical Group PLC
  • Biopac Systems Inc.
  • ATYS Medical
  • Perimed AB
  • ADInstruments
  • Getinge AB
  • Compumedics Limited

第13章 付録

目次
Product Code: MD1617

Overview

Blood flow measurement devices are designed to access and quantify blood flow within the human body. These devices play a crucial role in various medical specialties including cardiology, vascular surgery, and neurology.

Blood flow meters are used to monitor the blood flow in various blood vessels and to measure cardiac output. Ultrasound doppler, transit-time flow meters, electromagnetic blood flowmeters, and plethysmography chamber flow meters are the commonly used blood flow measurement devices.

Market Dynamics

Increasing product launches

The increasing number of product launches for foot blood flow measurement devices acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new blood flow measurement devices.

For instance, in June 2023, Stat Health launched an in-ear wearable that measures blood flow. It is designed wearable to help understand symptoms like dizziness, brain fog, headaches, fainting, and fatigue.

Additionally, in April 2021, NovaSignal Corp. launched the NovaGuide 2 Intelligent Ultrasound which autonomously measures the blood flow to identify brain illnesses and diseases.

Furthermore, the global blood flow measurement market is driven by various factors like the rising prevalence of cardiovascular diseases, technological advancements, and a rise in demand for blood flow measurement devices are expected to drive the market in the forecast period.

Stringent regulatory approvals

Stringent regulatory approvals for blood flow measurement devices can hamper the market growth as they involve rigorous testing and evaluation of the device to ensure specific standards for accuracy, reliability, and safety.

Segment Analysis

The global blood flow measurement market is segmented based on device type, application, end users and region.

Ultrasound devices accounted for approximately 38.9% of the market share

Doppler ultrasound is a noninvasive test that can be used to estimate the blood flow through the blood vessels by bouncing high-frequency sound waves. Ultrasound devices are expected to hold the largest market share over the period forecast owing to increasing new standard device launches and technological advancements.

For instance, in February 2022, Philips expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities for real-time blood flow on its handheld point-of-care ultrasound called Lumify.

Additionally, in August 2021, Trivitron launched SonoRad V60 Ultrasound. The device is equipped with innovative color flow technology that improves blood flow measurement and visualization and offers a 3D-like flow impression.

Geographical Analysis

North America is expected to hold a significant position in the global blood flow measurement devices market share

The global blood flow measurement devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising prevalence of cardiovascular disorders, and product launches, this trend is anticipated to continue throughout the forecast period.

For instance, according to the Centers for Disease Control and Prevention 2023 report, in the United States, heart disease is the top cause of death for both men and women. In the US, an estimated 805,000 people suffer a heart attack annually. Hence, the requirement for blood flow measurement devices increases due to the rising prevalence of cardiovascular diseases.

Additionally, in April 2023, GE HealthCare launched its next-generation intraoperative ultrasound called bkActiv system. It features a sensitive color Doppler to visualize and measure the speed and direction of blood flow during complex surgical procedures.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the global blood flow measurement devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the blood flow measurement devices market is expected to be moderately affected over the forecast period.

Competitive Landscape

The major global players in the market include: Cook Medical Inc., Medistim ASA, Transonic Systems, Inc., Deltex Medical Group PLC, Biopac Systems Inc., ATYS Medical, Perimed AB, ADInstruments, Getinge AB, Compumedics Limited among others.

Key Developments

  • In September 2023, Us2.ai partnered with Academic Medical Center to collaborate on AI-enabled echocardiography software. Us2.ai software automated measurements include 2-dimensional spectral Doppler and tissue Doppler.

Why Purchase the Report?

  • To visualize the global blood flow measurement devices market segmentation based on device type, application, end users and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of blood flow measurement devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global blood flow measurement devices market report would provide approximately 61 tables, 58 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing product launches
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent regulatory approvals
      • 4.1.2.2.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Ultrasound Devices *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Ultrasound Doppler
    • 7.2.4. Transit-Time Flow Meters
  • 7.3. Laser Doppler
  • 7.4. Electromagnetic Blood Flowmeters
  • 7.5. Plethysmography Chamber Flow meter

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Invasive *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. CABG
    • 8.2.4. Microvascular Surgery
  • 8.3. Non-Invasive
    • 8.3.1. Diabetes
    • 8.3.2. Cardiovascular Disease
    • 8.3.3. Tumor Monitoring
    • 8.3.4. Gastroenterology
    • 8.3.5. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Cook Medical Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medistim ASA
  • 12.3. Transonic Systems, Inc.
  • 12.4. Deltex Medical Group PLC
  • 12.5. Biopac Systems Inc.
  • 12.6. ATYS Medical
  • 12.7. Perimed AB
  • 12.8. ADInstruments
  • 12.9. Getinge AB
  • 12.10. Compumedics Limited

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us